The challenges to providing health care services for stroke in developing countries include lack of awareness about stroke risk factors, economic resources for well-functioning healthcare systems, unaffordable cost of tPA (tissue-type plasminogen activator), lack of rehabilitation facilities and preference for alternative and complementary medicines over modern medicines [12,28,30]. This evidence concerns the gene PLAT and Stroke.